Stock Update: Allergan Inc (NYSE:AGN) – Allergan Announces U.S. Availability of VIBERZI™ (eluxadoline) for Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults

[PR Newswire] – DUBLIN, Dec. 14, 2015 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced today that VIBERZI™ (eluxadoline), the company’s first-in-class treatment for irritable … Read more on . . . → Read More: Stock Update: Allergan Inc (NYSE:AGN) – Allergan Announces U.S. Availability of VIBERZI™ (eluxadoline) for Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults Similar Articles: Stock Update: Allergan Inc (NYSE:AGN) – Allergan drops appeal of order blocking Alzheimer’s drug switch Market Update: Allergan Inc (NYSE:AGN) – Allergan Announces Resolution Concluding Federal Investigation Into Warner Chilcott Sales And Marketing Practices Stock Update (NYSE:AGN): Allergan to Present New Data for VIBERZI™ (eluxadoline) at the American College of Gastroenterology 2015 Annual Scientific Meeting